Candy Industry
  Home
  Subscribe to Candy Industry
  Subscribe to Sweet & Healthy eNewsletter
  Subscription Customer Service
  Online
  Breaking News
  General News
  Industry Trends
  Ingredient Intelligence
  New Product Marketplace
  Packaging & Processing Technologies
  Personal Perspectives
  Podcasts
  Profiles
  Special Reports
  Supplier News
  Sweet & Healthy eNewsletter
  Webinars
  Current Issue
  Digital Edition
  Resources
  Archives
  Buyers Guide
  Calendar
  Classifieds
  Industry Links
  Market Research
  Events
  Food Safety & Security Summit
  Kettle Awards
  Packaging That Sells Conference
  Info
  Contact Us
  Media Kit
  Reprints
  List Rentals
Search in: EditorialProductsCompanies
Mastix Medica acquires Koko’s Confectionery private label division …

April 9, 2009

ARTICLE TOOLS
EmailEmailPrintPrintReprintsReprintsshareShare



Mastix Medica, a manufacturer of tableted functional food and nutritional supplement products, has acquired the private label division and pressed tablet factory of Koko’s Confectionery & Novelty Co., which currently manufactures tableted chewing gum and mints for contract manufacturing and private label customers, along with its own novelty candy products. Using Koko’s Confectionery’s 28,000-sq.-ft. tableting facility located in Baltimore County, Md., Mastix plans to continue growing the confectionery business by developing custom formulations that incorporate nutritional supplements into the category. Eventually, the company plans to manufacture and market its own healthcare products.

Additionally, Mastix expects product differentiation in the functional food, nutritional supplement and pharmaceutical sectors to become even more important.

“To meet these market needs, Mastix is focusing on developing products in emerging, underutilized dosage forms like orally disintegrating tablets and tableted chewing gum,” said Robert Estey, ceo of Mastix Medica. “Our directly compressible chewing gum tablets are an excellent delivery vehicle for nutritional supplements and, longer term, for pharmaceutical products.”


|PrintEmail

Did you enjoy this article? Click here to subscribe to the magazine.







-->













BNP Media
© 2010 BNP Media. All rights reserved. | Privacy Policy